BHCM
AVNS icon

Brevan Howard Capital Management’s Avanos Medical AVNS Stock Holding History

Brevan Howard Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,507
Closed -$353K – 1790
2025
Q3 		$353K Buy
30,507
+14,394
+89% +$169K ﹤0.01% 1477
2025
Q2 		$197K Sell
16,113
-16,059
-50% -$202K ﹤0.01% 1713
2025
Q1 		$461K Buy
+32,172
New +$502K ﹤0.01% 740

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's AVNS Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 30,507 shares — an estimated $353K sold.

Brevan Howard Capital Management first reported a position in AVNS in Q1 2025 and held it in 3 quarters. The position peaked at $461K in Q1 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 30,507 Avanos Medical shares in Q4 2025, an estimated $353K.
  • Brevan Howard Capital Management first reported a position in Avanos Medical in Q1 2025 and held it in 3 quarters.
  • Brevan Howard Capital Management's Avanos Medical position peaked at $461K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.